Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
25.83
+0.29 (1.14%)
Nov 17, 2026, 10:21 AM EST - Market open
Baxter International Revenue
Baxter International had revenue of $2.98B in the quarter ending September 30, 2026, with 4.97% growth. This brings the company's total for the last twelve months to $11.61B, up 5.33% year-over-year. In the year 2025, Baxter International had annual revenue of $11.24B with 5.72% growth. That makes Baxter International the 1,306th largest company in the world by revenue and 417th in the United States.
Revenue (ttm)
$11.61B
Revenue Growth
+5.33%
P/S Ratio
1.14
Revenue / Employee
$309,627
Employees
37,500
Market Cap
13.36B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Baxter International breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.24B | 608.00M | 5.72% |
| Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
| Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
| Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
| Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
| Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
| Dec 31, 2019 | 11.36B | 263.00M | 2.37% |
| Dec 31, 2018 | 11.10B | 515.00M | 4.87% |
| Dec 31, 2017 | 10.58B | 421.00M | 4.14% |
| Dec 31, 2016 | 10.16B | 195.00M | 1.96% |
| Dec 31, 2015 | 9.97B | -751.00M | -7.01% |
| Dec 31, 2014 | 10.72B | 1.31B | 13.87% |
| Dec 31, 2013 | 9.41B | -4.52B | -32.46% |
| Dec 31, 2012 | 13.94B | 43.00M | 0.31% |
| Dec 31, 2011 | 13.89B | 1.05B | 8.18% |
| Dec 31, 2010 | 12.84B | 281.00M | 2.24% |
| Dec 31, 2009 | 12.56B | 214.00M | 1.73% |
| Dec 31, 2008 | 12.35B | 1.09B | 9.63% |
| Dec 31, 2007 | 11.26B | 885.00M | 8.53% |
| Dec 31, 2006 | 10.38B | 529.00M | 5.37% |
| Dec 31, 2005 | 9.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Solventum | 8.16B |
| Avantor | 6.64B |
| ResMed | 5.73B |
| Bausch + Lomb | 5.42B |
| The Cooper Companies | 4.24B |
| Align Technology | 4.16B |
| AptarGroup | 3.99B |
| West Pharmaceutical Services | 3.40B |
BAX News
- 8 days ago - Baxter price target raised to $23 from $20 at Barclays - TheFly
- 18 days ago - Baxter price target lowered to $25 from $26 at JPMorgan - TheFly
- 18 days ago - Baxter price target lowered to $25 from $28 at Stifel - TheFly
- 18 days ago - Baxter price target lowered to $25 from $27 at Jefferies - TheFly
- 19 days ago - Baxter International Earnings Call Transcript: Q3 2026 - Transcripts
- 19 days ago - Baxter International Earnings release: Q3 2026 - Filings
- 19 days ago - Baxter International Slides: Q3 2026 - Filings
- 19 days ago - Baxter International Quarterly report: Q3 2026 - Filings